Table 1:

Patient characteristics for each molecular subtype

IDHmut-CodelIDHmut-NoncodelIDHwt
Total patientsa104 (34.0%)129 (42.2%)73 (23.9%)
Female sex58 (55.8%)61 (47.3%)35 (47.9%)
Ageb48 (17–74)35 (17–70)57 (19–76)
WHO grade
 II72 (69.2%)83 (64.3%)34 (46.6%)
 III32 (30.8%)46 (35.7%)39 (53.3%)

  • ↵a Data are listed as count (percentage of total cohort).

  • ↵b Data are listed as median (range). Other data are listed as count (percentage of cases within given molecular subtype).